In addition, immunohistochemical results showed that MYBPH was upregulated in clinical specimens from GBM patients and MYBPH expression was higher in tumor tissues than in the corresponding peritumor tissues and normal tissues (Fig. 2). Here, MYBPH is linked to neoplasm.